Log In
Copyright © 2009 American Chemical Society
September 28, 2009 Cover
Volume 87, Issue 39
COVER: Artist�s rendition shows thesurface of an influenza virus studded with hemagglutininand neuraminidase proteins.
Volume 87, Issue 39
HIN1 PANDEMIC
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
COVER: Artist�s rendition shows thesurface of an influenza virus studded with hemagglutininand neuraminidase proteins.
Credit: Novartis
» Full Article
September 28, 2009 Issue
Volume 87, Issue 39
September 28, 2009 Issue, Vol. 87 | Iss. 39
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
(pp. 15-26)
Features
Science & Technology
Advances in breeding and basic science confer drought tolerance to crops (pp. 60-62)
Cover Story: Flu Fighters
Flu Vaccine Race Against The Clock
Developers have made vaccines against the pandemic flu but now must deliver them in time
(pp. 27-33)News of the Week
Moon's Surface Holds Water
Planetary Science: Spectral results from three different spacecraft confirm presence of H2O or HO•
(p.9)Data Manipulation At ETH
Misconduct: Fabricated chemistry data at Switzerland's premier research institution leads to resignation
(p.11)Heads Butt Over Deadly Explosion
Dust Accident: Safety board seeks better maintenance; unions want tougher regulations
(p.12)Unusual Aluminum Bonding Geometry
Catalysis: Pentacoordinated Al joins Pt in supported catalysts
(p.12)Mass Spec As A Surgical Tool
Clinical Chemistry: Analytical technique can help distinguish cancerous from healthy tissue
(p.13)Unearthing Nature's Bounty
Chemical Biology: Mass spectrometry anchors tactic for finding new natural products from microbes
(p.13)Departments
Business
Investment flows into the U.S. as drugmakers reassess their supply chains
(pp. 38-41)
Small-molecule drugs to treat dry age-related macular degeneration are heading to the clinic
(pp. 43-45)
Colleagues, puzzled by charges, wonder whether it is all a misunderstanding
(pp. 47-48)
Developers have made vaccines against the pandemic flu but now must deliver them in time
(pp. 27-33)
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
(pp. 15-26)Concentrates
(pp. 35-36)
(pp. 35-36)- Green Lists Proliferate
- Solvay Indupa To Cut One Plant
- Ineos Nova Shuts Plant
- Lucite Closes A Third Unit
- Teijin, Chinese Firm Recycle Polyester
- Georgia Gulf Reworks Debt
- Borealis Donates Polyethylene
- Warner Sells Rights To Leo For $1 Billion
- Qiagen Acquires Diagnostics Maker
- AstraZeneca Licenses Two Nektar Compounds
- New Technology Bows At Seattle Genetics
- Animal-Health Deals In The Offing
- Business Roundup
- All Concentrates
ACS News
Governance bodies receive reports, debate election procedure
(pp. 70-72)
Government & Policy
Makers of brand-name biologics get closer to winning 12 years of exclusivity before generic versions can come to market
(pp. 51-53)
Direct-to-consumer companies are proliferating, raising questions about quality and lack of standards
(pp. 54-57)
Science & Technology
Advances in breeding and basic science confer drought tolerance to crops
(pp. 60-62)
Unique challenges face developers of drugs that hit disease-related RNAs rather than disease-related proteins
(pp. 63-66)